The F-35 Joint Program Office has announced that two F-35B Lightning II stealth aircraft begin sea trials aboard Italian aircraft carrier ITS Cavour (CVH 550). Test pilots flew the specially instrumented U.S. F-35Bs from Naval Air Station Patuxent River (NAS Pax River), Maryland, to the Italian Navy flagship, which got underway Sunday, February 28. The Lockheed Martin’s F-35B is the short take-off and vertical landing variant of the F-35. – ADVERTISEMENT – CONTINUE READING BELOW – The pilots and aircraft join a test team of approximately 180 personnel from the NAS Pax River-based F-35 Integrated Test Force (ITF) embarked for up […]
Trials
41 posts
https://cdn1.img.sputniknews.com/img/107337/45/1073374598_0:100:1920:1180_1200x675_80_0_0_89906fdf37bf08270d6fb2875d4c8fd9.jpg Sputnik International https://cdn2.img.sputniknews.com/i/logo.png Sputnik https://cdn2.img.sputniknews.com/i/logo.png https://sputniknews.com/india/202010071080695646-indian-drug-regulator-allows-human-trials-for-antibody-treatment-for-covid-19-developed-from-horses/ For the therapy, which works similarly to plasma therapy to treat the novel coronavirus, the blood plasma is taken from horses. There horses were injected with an inactivated COVID-19 virus. After 21 days, the plasma samples taken from horses’ blood showed antibodies against the virus. The Indian drug regulatory body, the Drugs Controller General of India (DCGI), has given a nod for conducting phase-1 human trials for the “antisera” treatment against COVID-19 developed by taking antibodies from the blood of horses. The antibody treatment “antisera” was developed by India’s apex medical research body, the Indian […]
https://cdn1.img.sputniknews.com/img/07e4/09/1c/1080597670_0:0:1200:675_1200x675_80_0_0_e166242b09fbe9105a921d666db1e3cb.jpg Sputnik International https://cdn2.img.sputniknews.com/i/logo.png Sputnik https://cdn2.img.sputniknews.com/i/logo.png https://sputniknews.com/europe/202009281080597719-first-batch-of-sputnik-v-vaccine-delivered-to-belarus/ MOSCOW (Sputnik) – The first batch of the Sputnik V coronavirus vaccine was delivered to Belarus for clinical trials, the Russian Direct Investment Fund (RDIF) announced Monday. “The Russian Direct Investment Fund (RDIF), Russia’s sovereign wealth fund, announces the delivery of the first batch of the Russian vaccine against coronavirus, Sputnik V, to the Republic of Belarus”, the fund said in a press release. The vaccination of volunteers will begin on 1 October as “part of double-blind, randomized, placebo-controlled clinical trials of the Sputnik V vaccine”, the press release read. The Russian sovereign wealth […]
In making sense of former Olympic and Paralympic sprinter Oscar Pistorius’ story, particularly the February 2013 night when he shot and killed his girlfriend, Reeva Steenkamp, it’s best to assume that you’ll never arrive at a satisfying set of answers. All of the evidence in the case in which he was convicted for culpable homicide—and later, murder—in 2014 was circumstantial. No one alive knows the why of what actually happened except Pistorius himself, but the new ESPN 30 for 30 four-part film, The Life and Trials of Oscar Pistorius, about the event as well as Pistorius’ career as a double-amputee runner, […]
https://cdn1.img.sputniknews.com/img/07e4/09/1a/1080576462_0:157:3071:1884_1200x675_80_0_0_c4b5f72aa47d41a2c705c60e3d7c1f75.jpg Sputnik International https://cdn2.img.sputniknews.com/i/logo.png Sputnik https://cdn2.img.sputniknews.com/i/logo.png https://sputniknews.com/us/202009261080576492-us-vaccine-reportedly-shows-strong-immune-response-to-coronavirus-in-clinical-trials/ WASHINGTON (Sputnik) – US pharmaceutical and medical device company Johnson and Johnson is reported to have developed a vaccine that, in early trials, shows a strong immune response to the novel coronavirus in a single dose, an interim report published on the medical website medRxiv has revealed. “The safety profile and immunogenicity after only a single dose are supportive for further clinical development of [vaccine] Ad26.COV2.S at a dose level of 5×1010 vp, as a potentially protective vaccine against COVID-19,” the report said on Friday. “A single dose of Ad26.COV2.S elicited strong humoral responses […]
The Russian Health Ministry has given its blessing to yet another home-baked coronavirus vaccine, this one based on an artificially weakened or “killed” virus, to be tested on hundreds of people. Some 3,000 volunteers will be taking part in clinical trials to be carried out in St. Petersburg, Novosibirsk, Russia’s third-largest city, and Kirov, a city in western Russia, some 900km northeast of Moscow. The Chumakov Federal Scientific Center for Research and Development of Immune and Biological Products, which developed the vaccine, shared the latest information with Russia’s RBK daily newspaper on Tuesday. The Center noted that the trials “will meet […]
Political Trials And Electoral Bans By Guillaume Long, Open Democracy. September 20, 2020 Political Trials And Electoral Bans2020-09-202020-09-20https://popularresistance-uploads.s3.amazonaws.com/uploads/2017/12/popres-shorter.pngPopularResistance.Orghttps://popularresistance-uploads.s3.amazonaws.com/uploads/2020/09/ecuador-e1600608073774.jpg200px200px Above photo: The outgoing President, Rafael Correa, right, received in the the Palace of Carondelet the president-elect Lenin Moreno for the official act of transition between the two governments in April 2017. Quito, Ecuador. Gabriela Mena / ACG/SIPA USA/PA Images. The Battle for Democracy in Ecuador. Amidst political trials and electoral bans, Moreno’s assault on democracy is past the point of no return. Ecuadorian President Lenín Moreno and his allies have gone to great lengths to prevent former president Rafael Correa and his political […]
BEIJING (Sputnik) – China is conducting clinical trials of 11 vaccines against the coronavirus disease, four of which are in phase 3, the country’s Science and Technology Minister Wang Zhigang said on Friday. “At the moment, 11 vaccines have entered the phase of clinical trials, four of them are already in phase 3,” Wang said while speaking at the Zhongguancun forum in Beijing. According to the minister, Chinese researchers focused on the development of five types of COVID-19 vaccine at once — a recombinant protein subunit vaccine, an inactivated vaccine, an adenoviral vector-based vaccine, a nucleic acid-based vaccine, and a live […]
A tech-focused subsidiary of Societe Generale said it will trial up to five different blockchains to understand their usefulness in capital markets. Source link
UPDATE ON SEPTEMBER, 11 The COVID-19 vaccine participant whose mysterious illness stopped the AstraZeneca coronavirus vaccine trials is reported to be an inflammatory syndrome known as transverse myelitis which may lead to paralysis. According to agreements with governments, the vaccine manufacturer cannot be legally held responsible for the side-effects of the coronavirus vaccine, for the ongonign pandemic emergency. The vaccine candidate, known as AZD1222 and developed with researchers at Oxford University Jenner Institue, was considered one of the promising. In April and May, researchers performed a combined Phase I and II trial that showed that the vaccine was safe, produced no unusual side-effects, […]
Jose Luis Pelaez Inc/Getty Images Jose Luis Pelaez Inc/Getty Images Black patients are some of the most reluctant to participate in clinical trials, according to FDA statistics. And their inclusion in the coronavirus vaccine trials has been a stated priority for the pharmaceutical companies involved, since African American communities, along with Latinos, have suffered disproportionately from the pandemic. But the trials are moving at a pace that is unprecedented for medical research, with the Trump administration’s vaccine acceleration effort dubbed “Operation Warp Speed.” Yet recruiting minority participants into these ongoing trials requires sensitivity to a legacy of mistrust based on past […]
Minneapolis prosecutors argued Friday that the four ex-cops charged in George Floyd’s death should face a single jury after participating in the May 25 incident “together”—but their lawyers argued a collective trial would be against the “interest of justice” in the latest indication the men are turning on each other. During a court appearance, attorneys for Derek Chauvin, Tou Thao, Thomas K. Lane, and J. Alexander Kueng argued each of their clients should get their own trial, highlighting the media scrutiny of the case and the differing roles each played in the tragic arrest. In filings prior to Friday’s hearing, each […]
by Fabio Giuseppe Carlo Carisio for VT Italy A twist on the front of the Oxford University Covid-19 vaccine developed by the Jenner Institute. A serious unforeseen induced the Anglo-Swedish pharmaceutical company (owned by the American investment funds of the Weapons Lobby as demonstrated in a previous report) to stop the trial process after a mysterious and inexplicable illness. WUHAN-GATES – 15. EU-Italy Covid Vaccine’ Business in Gates-Big Pharma’s Dirty Hands To give the preview of the news is the NBC network of the USA (full post below) where the most important tests of the vaccine developed in the United Kingdom by […]
After six trials and 23 years behind bars, charges are being dropped against Curtis Flowers (pictured here in Dec. 2019) over a 1996 quadruple killing in Mississippi. The U.S. Supreme Court struck down a conviction last summer, citing among other things, the deliberate elimination of Black jurors from Flowers’ trials. Rogelio V. Solis/AP hide caption toggle caption Rogelio V. Solis/AP After six trials and 23 years behind bars, charges are being dropped against Curtis Flowers (pictured here in Dec. 2019) over a 1996 quadruple killing in Mississippi. The U.S. Supreme Court struck down a conviction last summer, citing among other things, […]
Sputnik has spoken to the vaccine developers at the Gamaleya Centre, Alexander Gintsburg and Denis Logunov, as well as the CEO of the Russian Direct Investment Fund Kirill Dmitriev, to find out what data the article cites and why it is so important for the global scientific community. Today, less than a month after the Sputnik V COVID-19 vaccine was registered, the world’s most influential scientific journal The Lancet has published the results of the first two stages of clinical trials, so highly-anticipated by both the Russian and international scientific community. The article responds to foreign criticism and provides long-awaited clarity. […]
ANKARA (Sputnik) – The Turkish authorities may soon issue a permit for trials of Russian vaccine against coronavirus infection, the country’s health minister, Fahrettin Koca, said on Wednesday. “We have received a request to test a vaccine being developed in Russia. In the near future, I think, a permit will be issued for this. In addition, two domestic vaccines are currently being tested in the country,” Koca told reporters. He added that such tests were carried out in Turkey on volunteers exclusively. The Russian vaccine, which was registered on 11 August, was tested on 76 volunteers separately at two institutions — […]
https://cdn1.img.sputniknews.com/img/07e4/07/09/1079840937_0:105:2244:1367_1200x675_80_0_0_fcee7cdb2d3de9cc2c100986503dc20a.jpg Sputnik International https://cdn2.img.sputniknews.com/i/logo.png Sputnik https://cdn2.img.sputniknews.com/i/logo.png https://sputniknews.com/us/202008301080321718-us-drug-agency-says-covid-19-vaccine-may-be-authorised-before-end-of-phase-3-trials/ MOSCOW (Sputnik) – US Food and Drug Administration (FDA) is ready to authorise a vaccine against COVID-19 before the end of phase three clinical trials if such a move proves to bring more benefits than risks, Stephen Hahn, the head of the FDA, told the Financial Times (FT) in an interview, which was published on Sunday. “It is up to the sponsor to apply for authorisation or approval, and we make an adjudication of their application … If they do that before the end of Phase Three, we may find that appropriate. We may […]
A new CH-53K King Stallion heavy-lift helicopter from Sikorsky has completed sea trials, according to a company news release. “364 landings and takeoffs, day and night, from all nine deck spots. Two weeks of sea trials complete,” the release states. Testing took place on the USS Wasp, a landing helicopter dock (LHD) amphibious assault ship operated by the U.S. Navy, and was the first opportunity to operate the King Stallion in a modern naval environment. The June sea trials were the first in a series of three planned sea exercises to fully evaluate the aircraft’s performance and shipboard compatibility. – ADVERTISEMENT […]
Pentagon’s No.1 weapons supplier Lockheed Martin Corp has announced that the future USS Minneapolis-Saint Paul, completed acceptance trials in Lake Michigan. Littoral Combat Ship (LCS) 21, the future USS Minneapolis-Saint Paul, passed several trials including a full-power run, maneuverability testing and surface and air detect-to-engage demonstrations of the ship’s combat system. “LCS 21 joins a fleet of sister ships delivering unique flexibility and capability to the U.S. Navy,” said Joe DePietro, Lockheed Martin vice president and general manager, Small Combatants and Ship Systems. “Freedom-variant LCS are inherently capable to serve freedom of navigation, drug interdiction and humanitarian missions, and with additional capabilities onboarded, […]
Italy on Monday launched human trials of GRAd-COV2, a potential COVID-19 vaccine developed by Rome-based biotechnology company ReiThera. The trial is being conducted by Rome’s Lazzaro Spallanzani Hospital, which specializes in infectious diseases. Over the next few weeks, 90 volunteers will receive the vaccine, Reuters reported. Francesco Vaia, the hospital’s health director, told Reuters the first patient to receive the vaccine was a 50-year-old woman who was monitored for four hours before being permitted to go home. The unidentified woman will remain under observation for 12 weeks at home to determine if she produced any antibodies to the novel coronavirus or […]
https://cdn1.img.sputniknews.com/img/07e4/08/05/1080078068_0:0:1366:768_1200x675_80_0_0_7a50cc442e6b253716941a590adb61ea.png Sputnik International https://cdn2.img.sputniknews.com/i/logo.png Sputnik https://cdn2.img.sputniknews.com/i/logo.png https://sputniknews.com/military/202008051080078114-video-chinas-type-075-helicopter-carrier-sets-sail-for-first-sea-trials/ China’s first amphibious assault ship, the Type 075 landing helicopter dock (LHD), has been put to sea for the first time on Wednesday. Photos and video on social media showed the warship being escorted away from the docks by the Hudong Zhonghua shipyard in Shanghai by tugboats on Wednesday morning, before steaming away under its own power. Judged to be between 35,000 and 40,000 tons displacement, the Type 075 is the rough equivalent of the US Navy’s Wasp-class amphibious assault ships. This class of warship has both a flight deck for launching helicopters or […]
Austal USA shipyard announced that the future USNS Newport, the 12th Spearhead-class Expeditionary Fast Transport ship built for the U.S. Navy has successfully completed acceptance trials in the Gulf of Mexico. USNS Newport is the 12th Spearhead-class Expeditionary Fast Transport ship built by Austal USA in Mobile, Alabama, for the United States Navy (USN). Austal Chief Executive Officer David Singleton said the successful completion of acceptance trials for EPF 12 was yet another important milestone for a program that has seen 11 vessels delivered to the US Navy in less than 8 years. – ADVERTISEMENT – CONTINUE READING BELOW – “Austal’s […]
A team of researchers in Siberia’s largest city have been granted a permit by the Russian health ministry to conduct a clinical trial of their potential coronavirus vaccine. The first volunteers will be inoculated on July 27. Rospotrebnadzor, Russia’s health watchdog, said the Novosibirsk-based Vektor State Research Center of Virology and Biotechnology was given the green light on Friday. The authority’s chief Anna Popova announced that her monitors were satisfied with the results of the first stage of development. Earlier, the Ministry of Defense announced the successful completion of clinical trials of another possible Covid-19 vaccine, which it developed jointly with […]
https://cdn1.img.sputniknews.com/img/07e4/07/14/1079933849_0:0:3070:1727_1200x675_80_0_0_1cf93ea0472a92b97960b86c6d8bbcba.jpg Sputnik International https://cdn2.img.sputniknews.com/i/logo.png Sputnik https://cdn2.img.sputniknews.com/i/logo.png https://sputniknews.com/world/202007241079976643-human-trials-of-russias-second-covid-19-vaccine-to-start-july-27/ MOSCOW (Sputnik) – Russian State Research Center of Virology and Biotechnology Vector received permission to conduct clinical trials of a vaccine against coronavirus, the first volunteers will receive it on July 27, Russian healthcare watchdog Rospotrebnadzor said on Friday. “Rospotrebnadzor’s Vector Center received permission on July 24 to conduct clinical trials of the vaccine, the first volunteers will be vaccinated on July 27 as part of the clinical trial protocol,” the statement says. Another Russian vaccine, developed by the Gamaleya Institute of Epidemiology and Microbiology, is undergoing clinical trials at two institutions: the Burdenko […]
MOSCOW (Sputnik) – The Russian Defence Ministry said on Monday that clinical trials of Russia’s coronavirus vaccine conducted jointly with the Gamaleya Scientific Research Institute of Epidemiology and Microbiology on 20 volunteers had been completed, adding that all the participants had been discharged. “The Russian Defence Ministry together with the Gamaleya Scientific Research Institute of Epidemiology and Microbiology has successfully completed clinical trials of the vaccine against COVID-19 with the participation of volunteers at the Burdenko Main Military Clinical Hospital”, the ministry said in a statement. The ministry said that the second group of 20 volunteers had been discharged. “Test results […]
MOSCOW (Sputnik) – Clinical trials of a Russia COVID-19 vaccine developed by the Gamaleya Scientific Research Institute of Epidemiology and Microbiology jointly with the Russian Defence Ministry are wrapping up at the Burdenko Main Military Clinical Hospital. The vaccine is safe and reliable, researchers say. “The clinical trials of the Russian vaccine against the coronavirus are ending at the Burdenko hospital […] Today, on July 20, the second and last group of volunteers comprising 20 people is being released from the military hospital,” Sergey Borisevich, head of the 48th Central Scientific Research Institute of the Russian Defence Ministry, told Krasnaya Zvezda, […]
** Dr. Tony Fauci and Dr. Deborah Birx used the Imperial College Model to persuade President Trump to lock down the ENTIRE US ECONOMY.** The fraudulent model predicted 2.2 million American deaths from the coronavirus pandemic** The authors of the Imperial College Model shared their findings with the White House Coronavirus task force in early March** Dr. Fauci and Dr. Birx then met with President Trump privately and urged him to shut down the US economy and destroy the record Trump economy based on this model** A new critique of the Imperial College Model finds the study is “completely unusable for […]
https://cdn1.img.sputniknews.com/img/107968/45/1079684551_0:27:3072:1755_1200x675_80_0_0_3a460a9f81b1161d0ccf521cafed54be.jpg Sputnik International https://cdn2.img.sputniknews.com/i/logo.png Sputnik https://cdn2.img.sputniknews.com/i/logo.png https://sputniknews.com/russia/202007121079860277-russias-sechenov-university-successfully-completes-trials-of-worlds-1st-covid-19-vaccine/ MOSCOW (Sputnik) – The clinical trials of the world’s first coronavirus vaccine on volunteers at the Sechenov First Moscow State Medical University have been successfully completed, Vadim Tarasov, the director of the Institute for Translational Medicine and Biotechnology, told Sputnik. The university began clinical trials of a vaccine produced by Russia’s Gamalei Institute of Epidemiology and Microbiology on 18 June. “Sechenov University has successfully completed tests on volunteers of the world’s first vaccine against coronavirus”, Tarasov said. He added that the first group of volunteers would be discharged on Wednesday and the second on […]
NIH launches clinical trials network to test COVID-19 vaccines and other prevention tools NIH News Release The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has established a new clinical trials network that aims to enroll thousands of volunteers in large-scale clinical trials testing a variety of investigational vaccines and monoclonal antibodies intended to protect people from COVID-19. The COVID-19 Prevention Trials Network (COVPN) was established by merging four existing NIAID-funded clinical trials networks: the HIV Vaccine Trials Network (HVTN), based in Seattle; the HIV Prevention Trials Network (HPTN), based in Durham, N.C.; the […]
NIH ACTIV vaccine working group weighs role of human challenge studies for SARS-CoV-2 vaccine development NIH News Release In a Perspective for the New England Journal of Medicine(link is external), members of the National Institutes of Health’s Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) Vaccines Working Group assess practical considerations and prerequisites for using controlled human infection models (CHIMs), which can be used for human challenge studies, to support SARS-CoV-2 vaccine development. In the article, the authors determine the timeline for developing robust CHIMs that meet the essential criteria for limiting risk for study volunteers could take one to two years. The authors […]
The World Health Organization (WHO) has stopped the clinical trials of the anti-malarial drug hydroxychloroquine as well as the anti-HIV medication lopinavir/ritonavir in coronavirus patients, following preliminary results. The United Nations health agency has said that the use of hydroxychloroquine – a drug once actively endorsed by the US President Donald Trump as a treatment against Covid-19 – should be discontinued, because it has little to no effect on halting the disease’s progression. Also on rt.com ‘No evidence of benefit’: FDA says hydroxychloroquine no longer approved for Covid-19 emergency use The decision was taken after the preliminary results of clinical trials […]
Russia has begun trials of the new Marker unmanned ground system, the Russian Foundation for Advanced Research Projects announced on 29 June. The Marker unmanned ground system is the joint project of the Center and the Android Technics Scientific Production Association. The modular platform is supposed to become the key element for practice of joint operation of ground robots, unmanned aviation and Special Operations forces. The Marker is positioned as a construction set for development of combat models in the future. The final testing stage of the Marker robot will take place in 2021, then the robot will be handed over […]
Health Editor’s Note: Currently the antiviral remdesivir is being given by intravenous infusions to COVID-19 patients and has been shown to shorten the time to recovery. Gilead has been given the go ahead to work on an inhaled version which will be far easier to give to a patient. An inhaled version would allow for dosing outside a hospital atmosphere and also for earlier treatment…..Carol Gilead is about to start trials of an inhaled version of remdesivir by Open Letter from Daniel O’Day, Chairman and CEO, Gilead Sciences After receiving the green light from the FDA to move forward, Gilead is […]
The Admiral Kasatonov frigate is capable of destroying surface ships, convoys and airborne military units, along with searching and targeting submarines and providing anti-aircraft, anti-submarine and anti-missile defence. #ВМФ 🇷🇺#Russian #Navy The second warship of project 22350 the RFS 431 ‘Admiral Kasatonov’, a Admiral Gorshkov Class frigate completed of sea trials and returned to Severnaya Verf (‘Northern Shipyard’) in #SaintPetersburg on 6th June 2020. pic.twitter.com/Cwc3OxwSyp — Capt(N) (@Capt_Navy) June 7, 2020 The Russian Project 22350 warship, the ‘Admiral Flota Kasatonov’, created using stealth technologies, has completed state trials in the sea and will soon be commissioned to the Russian fleet, according to […]
The Offshore Operators Committee, a nonprofit organization focused on offshore energy, has found a blockchain management system reduces costs and time for transporting wastewater. The (OOC)’s Oil and Gas Blockchain Consortium has completed its first pilot of a produced water haulage management system using blockchain technology. The pilot, the first industry-wide use of a blockchain-native network for produced water haulage, essentially tried to streamline the process of transporting wastewater byproducts collected during the extraction of oil and natural gas, referred to as produced water. The pilot automatically measured volume and generated invoices during the transportation process. Developed in partnership with Data […]
The Navy’s newest Independence-class littoral combat ship, the future USS Oakland (LCS 24), successfully concluded acceptance trials here May 22 following a series of in-port and underway demonstrations in the Gulf of Mexico. Austal Chief Executive Officer David Singleton said the successful completion of acceptance trials for LCS 24 during the COVID-19 pandemic has demonstrated Austal USA’s capability and reliability to deliver vessels on time, even under COVID-19 challenging circumstances. “Austal USA has clearly answered the call, as part of a mission-essential industry, to continue operations during the COVID-19 pandemic and deliver on commitments to the US Navy,” Mr Singleton said. […]
Novavax is testing a new coronavirus vaccine on human subjects for the first time, launching a phase one clinical trial with a massive grant from an agency founded by Bill Gates, kicking off a storm of concerns online. The Maryland-based pharma company has begun its trial, which will dose some 130 Australian participants with the new inoculation, hoping to see results as early as July and proceed to the second phase. Also on rt.com Hotly-touted Oxford coronavirus VACCINE trial has only 50 percent chance of success, project leader warns “Administering our vaccine in the first participants of this clinical trial is […]
RT/Moscow: The World Health Organization has paused the clinical trials of anti-malarial drug hydroxychloroquine in coronavirus patients. It says the drug, notably taken and endorsed by US President Donald Trump, has raised safety concerns. The drug’s safety data is being reviewed by a monitoring board, and the trials have been put on hold, the WHO chief Tedros Adhanom Ghebreyesus told reporters. It was being tested as part of the Solidarity international program aimed at tackling the Covid-19 pandemic. The UN health body took the step out of an “abundance of caution,” said Mike Ryan, the head of the organization’s emergencies program. Ghebreyesus said […]
25 May, 2020 17:31 Follow RT on The World Health Organization has paused the clinical trials of anti-malarial drug hydroxychloroquine in coronavirus patients. It says the drug, notably taken and endorsed by US President Donald Trump, has raised safety concerns. The drug’s safety data is being reviewed by a monitoring board, and the trials have been put on hold, the WHO chief Tedros Adhanom Ghebreyesus told reporters. It was being tested as part of the Solidarity international program aimed at tackling the Covid-19 pandemic. The UN heath body took the step out of “abundance of caution,” said Mike Ryan, the head […]
The U.S. Pacific Fleet has reported that Virginia-class fast-attack submarine USS Missouri (SSN 780) departs Pearl Harbor Naval Shipyard after completing a scheduled extended dry-docking selected restricted availability (EDSRA). According to a recent service news release, during the maintenance period, the shipyard and crew performed tank blasting and coating, hull preservation, propulsion and ship system repairs, and made enhancements to mechanical and electrical systems. Following sea trials, the crew will work together to maintain readiness prior to completing their certification for overseas deployment to support theater and national tasking. Fast-attack submarines are multi-mission platforms enabling five of the six Navy maritime […]
World 12:53 GMT 08.05.2020Get short URL New Delhi (Sputnik): Since the world might have to wait for a coronavirus vaccine to be developed, countries are pinning hopes on already existing drugs that could mitigate the effects of the virus. The Drug Controller General of India (DGCI) has given a nod to clinical trials of the drug favipiravir, which is used in influenza, against COVID-19. While approving the drug for trial, Director-General Shekhar Mande stated that it could potentially be useful against the coronavirus. Favipiravir, sold under the name Avigan, was first developed six years ago by a Japanese pharmaceutical company called […]